Abstract
Leptomeningeal disease (LMD) is a highly aggressive and usually rapidly fatal condition. The purpose of this study is to identify clinical factors that can serve to predict for LMD at the time of stereotactic radiosurgery (SRS) for brain metastases from breast carcinoma. We conducted a retrospective review of patients with brain metastases from breast cancer treated with SRS from 1995 to 2014 at our institution. Clinical, radiographic, and dosimetric data were collected. LMD was diagnosed by cerebrospinal fluid (CSF) cytology or MRI demonstrating CSF seeding. Comparative statistical analyses were conducted using Cox proportional hazards regression, binary logistic regression, and/or log-rank test. 126 patients met inclusion criteria. Eighteen patients (14 %) developed LMD following SRS. From the time of SRS, the actuarial rate of LMD at 12 months from diagnosis of brain metastasis was 9 % (11 patients). Active disease in the chest at the time of SRS was associated with development of LMD (p = 0.038). Factors including receptor status, tumor size, number of intra-axial tumors, cystic tumor morphology, prior WBRT, active bone metastases, and active liver metastases were not significantly associated with the development of LMD. In patients with brain metastasis from breast cancer that undergo SRS, there is a relatively low rate of LMD. We found that while tumor hormonal status, bone metastases, and hepatic metastases were not associated with the development of LMD, active lung metastases at SRS was associated with LMD. Further research may help to delineate a causative relationship between metastatic lung disease and LMD.
Similar content being viewed by others
References
Kontani K, Hashimoto S, Murazawa C, Norimura S, Tanaka H, Ohtani M, Fujiwara-Honjo N, Date M, Teramoto K, Houchi H, Yokomise H (2014) Factors responsible for long-term survival in metastatic breast cancer. World J Surg Oncol 12:344. doi:10.1186/1477-7819-12-344
Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77(3):655–661. doi:10.1016/j.ijrobp.2009.08.025
O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR (2003) A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 55(5):1169–1176
Kocher M, Maarouf M, Bendel M, Voges J, Muller RP, Sturm V (2004) Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al.] 180(5):263–267. doi:10.1007/s00066-004-1180-y
Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665–1672. doi:10.1016/s0140-6736(04)16250-8
Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044. doi:10.1016/S1470-2045(09)70263-3
Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD (2014) Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neuro-Oncol 120(1):163–169. doi:10.1007/s11060-014-1539-6
Atalar B, Modlin LA, Choi CY, Adler JR, Gibbs IC, Chang SD, Harsh GR, Li G, Nagpal S, Hanlon A, Soltys SG (2013) Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 87(4):713–718. doi:10.1016/j.ijrobp.2013.07.034
Suki D, Abouassi H, Patel AJ, Sawaya R, Weinberg JS, Groves MD (2008) Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 108(2):248–257. doi:10.3171/jns/2008/108/2/0248
Jo KI, Lim DH, Kim ST, Im YS, Kong DS, Seol HJ, Nam DH, Lee JI (2012) Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery. J Neuro-Oncol 109(2):293–299. doi:10.1007/s11060-012-0892-6
de Azevedo CR, Cruz MR, Chinen LT, Peres SV, Peterlevitz MA, de Azevedo Pereira AE, Fanelli MF, Gimenes DL (2011) Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. J Neuro-Oncol 104(2):565–572. doi:10.1007/s11060-010-0524-y
Meattini I, Livi L, Saieva C, Franceschini D, Marrazzo L, Greto D, Scotti V, Scoccianti S, Paiar F, Bordi L, Nori J, Sanchez L, Orzalesi L, Bianchi S, Biti G (2012) Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience. J Chemother (Florence, Italy) 24(5):279–284. doi:10.1179/1973947812y.0000000034
Xu Z, Schlesinger D, Toulmin S, Rich T, Sheehan J (2012) Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases. Int J Radiat Oncol Biol Phys 84(3):612–618. doi:10.1016/j.ijrobp.2011.12.054
Torrejon D, Oliveira M, Cortes J, Sanchez-Olle G, Gomez P, Bellet M, Saura C, Peg V, Rovira A, Di Cosimo S (2013) Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis. Breast (Edinburgh, Scotland) 22(1):19–23. doi:10.1016/j.breast.2012.10.009
Siomin VE, Vogelbaum MA, Kanner AA, Lee SY, Suh JH, Barnett GH (2004) Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery. J Neuro-Oncol 67(1–2):115–121
Ojerholm E, Lee JY, Thawani JP, Miller D, O’Rourke DM, Dorsey JF, Geiger GA, Nagda S, Kolker JD, Lustig RA, Alonso-Basanta M (2014) Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. J Neurosurg 121(Suppl):75–83. doi:10.3171/2014.6.gks14708
Page BR, Huang AJ, Huang KE, Laxton AW, Tatter SB, Chan MD (2014) Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases. Paper presented at the American Society for Radiation Oncology Annual Meeting, San Francisco, CA
Tallet AV, Azria D, Le Rhun E, Barlesi F, Carpentier AF, Goncalves A, Taillibert S, Dhermain F, Spano JP, Metellus P (2014) Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer. Int J Mol Sci 15(5):8138–8152. doi:10.3390/ijms15058138
Le Rhun E, Taillibert S, Devos P, Zairi F, Turpin A, Rodrigues I, Cazin JL, Pierret MF, Andre C, Dubois F, Bonneterre J, Chamberlain MC (2013) Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series. Anti-Cancer Drugs 24(10):1093–1097. doi:10.1097/cad.0000000000000010
Le Rhun E, Taillibert S, Zairi F, Pannier D, Boulanger T, Andre C, Cazin JL, Dubois F, Bonneterre J, Chamberlain MC (2013) Prolonged survival of patients with breast cancer-related leptomeningeal metastases. Anticancer Res 33(5):2057–2063
Clarke JL (2012) Leptomeningeal metastasis from systemic cancer. Continuum (Minneap Minn) 18(2):328–342. doi:10.1212/01.CON.0000413661.58045.e7
Pauls S, Fischer AC, Brambs HJ, Fetscher S, Hoche W, Bommer M (2012) Use of magnetic resonance imaging to detect neoplastic meningitis: limited use in leukemia and lymphoma but convincing results in solid tumors. Eur J Radiol 81(5):974–978. doi:10.1016/j.ejrad.2011.02.020
An YJ, Cho HR, Kim TM, Keam B, Kim JW, Wen H, Park CK, Lee SH, Im SA, Kim JE, Choi SH, Park S (2015) An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients. Int J Cancer 136(1):162–171. doi:10.1002/ijc.28949
Wang P, Piao Y, Zhang X, Li W, Hao X (2013) The concentration of CYFRA 21–1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer. Cancer Biomark 13(2):123–130. doi:10.3233/cbm-130338
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Trifiletti, D.M., Romano, K.D., Xu, Z. et al. Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer. J Neurooncol 124, 421–427 (2015). https://doi.org/10.1007/s11060-015-1854-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-015-1854-6